Koninklijke KPN N.V. (LON:0O8F)
 4.018
 -0.020 (-0.50%)
  At close: Oct 31, 2025
Koninklijke KPN Revenue
Koninklijke KPN had revenue of 1.46B EUR in the quarter ending September 30, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 5.78B, up 3.31% year-over-year. In the year 2024, Koninklijke KPN had annual revenue of 5.60B with 3.02% growth.
Revenue (ttm) 
 5.78B EUR
Revenue Growth 
 +3.31%
P/S Ratio 
 2.63
Revenue / Employee 
 559.57K EUR
Employees 
 10,333
Market Cap 
13.25B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 5.60B | 164.00M | 3.02% | 
| Dec 31, 2023 | 5.44B | 127.00M | 2.39% | 
| Dec 31, 2022 | 5.31B | 42.00M | 0.80% | 
| Dec 31, 2021 | 5.27B | -14.00M | -0.26% | 
| Dec 31, 2020 | 5.28B | -216.00M | -3.93% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 200.18B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |